Patent 11174284 was granted and assigned to Scarab Genomics on November, 2021 by the United States Patent and Trademark Office.
The present invention relates to the use of redox agents for purification of the CRM 197 variant of diphtheria toxin. The invention further relates to multi-step purification of CRM 197 from bacterial fermentates.